Vascular endothelial growth factor increases the intracellular magnesium

Vascular endothelial growth factor (VEGF) is one of the key players in the process of angiogenesis. However, its underlying mechanism remains unclear. Mg2+ is the most abundant intracellular divalent cation in the body and plays critical roles in many cell functions. We investigated the effect of VEGF on intracellular Mg2+ in human umbilical vein endothelial cells (HUVECs). VEGF-A(165) increased the intracellular Mg2+ concentration ([Mg2+](i)) in a dose-dependent manner, with or without extracellular Mg2+, and the increase of [Mg2+], was blocked by pretreatment with SU1498, tyrosine kinase inhibitors (tyrphostin A-23 and genistein), phosphatidylinositol 3-kinase (PI3K) inhibitors (wortmannin and LY294002) or phospholipase C gamma (PLC gamma) inhibitor (U73122). In contrast, mitogen-activated protein kinase inhibitors (SB202190 and PD98059) had no effect on the VEGF-induced [Mg2+], increase. These results suggest that VEGF-A165 increases the [Mg2+], from the intracellular Mg2+ stores through the tyrosine kinase/PI3K/PLC gamma-dependent signaling pathways. (c) 2006 Elsevier Inc. All rights reserved.